Search

OBJETIVO: Conocer la frecuencia de portadores nasales de cepas de Staphylococcus aureus resistentes a meticilina (SARM) y el patrón de resistencia antimicrobiana de esas cepas obtenidas de trabajadores de la salud de cuatro hospitales de Nicaragua. MÉTODOS: Se realizó un estudio descriptivo, transversal, en el período del 1 de junio de 2009 al 30 de septiembre de 2010. Los hisopados nasales de los trabajadores de la salud que aceptaron voluntariamente participar en el estudio fueron cultivados en medio agar base de detección de resistencia a oxacilina (ORSAB). La identificación de los aislados de S. aureus se realizó por métodos cotidianos y la resistencia a meticilina se determinó por la presencia del gen mecA con la técnica de reacción en cadena de polimerasa. El patrón de resistencia antimicrobiana se detectó por difusión en disco. Cada participante firmó un consentimiento informado con anterioridad a la toma de la muestra. RESULTADOS: Participaron en el estudio 569 trabajadores de la salud, de los cuales 208 eran del hospital de León, 155 de dos hospitales de Chinandega y 206 del de Managua. La frecuencia de portadores nasales de SARM fue de 9,6% en León, 11,6% en Chinandega y 6,7% en Managua. El perfil de resistencia de las cepas SARM fue similar en los cuatro hospitales y todas las cepas fueron sensibles a vancomicina. Del total de cepas SARM aisladas, 15% fueron multirre-sistentes. El porcentaje de resistencia a eritromicina fue el más alto, seguido del de clindamicina. CONCLUSIONES: Los resultados del estudio se pueden considerar una advertencia sobre la circulación de cepas SARM entre el personal de salud de los hospitales participantes y aportan información relevante en relación al perfil de resistencia de las cepas SARM.OBJECTIVE: To determine the frequency of nasal carriers of strains of methicillin-resistant Staphylococcus aureus (MRSA) and the antimicrobial resistance pattern of these strains, obtained from health workers from four hospitals in Nicaragua. METHODS: A descriptive cross-sectional study was conducted between 1 June 2009 and 30 September 2010. Nasal swabs were taken from health workers who voluntarily agreed to participate in the study, and were cultured on an oxacillin-resistant screening agar base (ORSAB) medium. The S. aureus isolates were identified using ordinary methods, and methicillin resistance was confirmed based on the presence of the mecA gene using the polymerase chain reaction technique. The antimicrobial resistance pattern was detected by the disk diffusion method. Each participant signed an informed consent form before the samples were taken. RESULTS: A total of 569 health workers participated in the study: 208 from one hospital in León, 155 from two hospitals in Chinandega, and 206 from one hospital in Managua. The frequency of nasal MRSA carriers was 9.6% in León, 11.6% in Chinandega, and 6.7% in Managua. The MRSA resistance profile was similar in the four hospitals, and all the strains were sensitive to vancomycin. Of the total MRSA strains isolated, 15% were multi-drug resistant. Erythromycin had the highest percentage of resistance, followed by clindamycin. CONCLUSIONS: The results of the study may be regarded as a warning that MRSA strains are circulating among health workers in the participating hospitals. The study also contributes important information regarding the resistance profile of MRSA strains.

We estimated the incidence of watery diarrhea in the community before and after introduction of the pentavalent rotavirus vaccine in León, Nicaragua. A random sample of households was selected before and after rotavirus vaccine introduction. All children < 5 years of age in selected households were eligible for inclusion. Children were followed every 2 weeks for watery diarrhea episodes. The incidence rate was estimated as numbers of episodes per 100 child-years of exposure time. A mixed effects Poisson regression model was fit to compare incidence rates in the pre-vaccine and vaccine periods. The pre-vaccine cohort (N = 726) experienced 36 episodes per 100 child-years, and the vaccine cohort (N = 826) experienced 25 episodes per 100 child-years. The adjusted incidence rate ratio was 0.60 (95% confidence interval [CI] 0.40, 0.91) during the vaccine period versus the pre-vaccine period, indicating a lower incidence of watery diarrhea in the community during the vaccine period.

Rheumatic heart disease (RHD) results in morbidity and mortality that is disproportionate among individuals in developing countries compared to those living in economically developed countries. The global burden of disease is uncertain because most previous studies to determine the prevalence of RHD in children relied on clinical screening criteria that lacked the sensitivity to detect most cases. The present study was performed to determine the prevalence of RHD in children and young adults in Leon, Nicaragua, an area previously thought to have a high prevalence of RHD. This was an observational study of 3,150 children aged 5 to 15 years and 489 adults aged 20 to 35 years randomly selected from urban and rural areas of Leon. Cardiopulmonary examinations and Doppler echocardiographic studies were performed on all subjects. Doppler echocardiographic diagnosis of RHD was based on predefined consensus criteria that were developed by a working group of the World Health Organization and the National Institutes of Health. The overall prevalence of RHD in children was 48 in 1,000 (95% confidence interval 35 in 1,000 to 60 in 1,000). The prevalence in urban children was 34 in 1,000, and in rural children it was 80 in 1,000. Using more stringent Doppler echocardiographic criteria designed to diagnose definite RHD in adults, the prevalence was 22 in 1,000 (95% confidence interval 8 in 1,000 to 37 in 1,000). In conclusion, the prevalence of RHD among children and adults in this economically disadvantaged population far exceeds previously predicted rates. The findings underscore the potential health and economic burden of acute rheumatic fever and RHD and support the need for more effective measures of prevention, which may include safe, effective, and affordable vaccines to prevent the streptococcal infections that trigger the disease.